Document:

Employment Agreement Between Sensata Technologies, Inc. and Jeffrey Cote

 Exhibit 10.29 
 EXECUTION COPY 
 EMPLOYMENT AGREEMENT 
 THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made as of November 30, 2006, between Sensata Technologies, Inc., a Delaware
corporation (the “Company”), and Jeffrey Cote (“Executive”). 
 In consideration of the mutual covenants
contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
 1. Employment. The Company shall employ Executive, and Executive hereby accepts employment with the Company, upon the terms and conditions set forth in this Agreement for the period beginning on the date hereof
and ending as provided in paragraph 4 hereof (the “Employment Period”). 
 2. Position and Duties. 
 (a) During the Employment Period, Executive shall serve as the Chief Financial Officer, of the Company and shall have the normal duties, responsibilities,
functions and authority of the Chief Financial Officer, subject to the power and authority of the Company’s Board of Directors (the “Board”), in consultation with the Company’s Chief Executive Officer (the “Chief
Executive Officer”), to expand or limit such duties, responsibilities, functions and authority and to overrule actions of officers of the Company. During the Employment Period, Executive shall render to Parent and its Subsidiaries
administrative, financial and other executive and managerial services that are consistent with Executive’s position as the Board may from time to time direct. 
 (b) Executive shall report to the Chief Executive Officer and the Board, and Executive shall devote his full business time and attention (except for vacation periods consistent with past practice and reasonable
periods of illness or other incapacity) to the business and affairs of Parent and its Subsidiaries. In performing his duties and exercising his authority under the Agreement, Executive shall support and implement the business and strategic plans
approved from time to time by the Board and shall support and cooperate with Parent’s and its Subsidiaries’ efforts to expand their businesses and operate profitably and in conformity with the business and strategic plans approved by the
Board. So long as Executive is employed by the Company, Executive shall not, without the prior written consent of the Board, perform other services for compensation. Unless otherwise agreed by Executive, Executive’s place of work shall be in
the greater Attleboro, Massachusetts metropolitan area, except for travel reasonably required for Company business. 
 (c) For purposes of
this Agreement, “Subsidiaries” shall mean any corporation or other entity of which the securities or other ownership interests having the voting power to elect a majority of the board of directors or other governing body are, at the
time of determination, owned by Parent, directly or through one or more Subsidiaries. 

 (d) For purposes of this Agreement, “Affiliate” shall mean with respect to Parent and
its Subsidiaries, any other Person controlling, controlled by or under common control with Parent or any of its Subsidiaries and, in the case of a Person which is a partnership, any partner of the Person. 
 (e) For purposes of this Agreement, “Person” shall mean an individual, a partnership, a corporation, a limited liability company, an
association, a joint stock company, a trust, a joint venture, an unincorporated organization and a governmental entity or any department, agency or political subdivision thereof. 
 (f) For purposes of this Agreement, “Parent” shall mean Sensata Technologies Holding B.V., a private limited company incorporated under
the laws of the Netherlands. 
 3. Compensation and Benefits. 
 (a) During the Employment Period, Executive’s base salary shall be $350,040.00 per annum and shall be subject to review by the Board, after
consultation with the Chief Executive Officer, on an annual basis commencing January 1, 2007 (as adjusted from time to time, the “Base Salary”), which salary shall be payable by the Company in regular installments in accordance
with the Company’s general payroll practices (in effect from time to time). In addition, during the Employment Period, Executive shall be entitled to participate in all of the Company’s employee benefit programs for which senior executive
employees of Parent and its Subsidiaries are generally eligible (assuming Executive and/or his family meet the eligibility requirements of those benefit programs), as well as the benefit programs listed on Annex A, which are currently in
effect in addition to employee benefit programs for which executive employees of Parent and its Subsidiaries are generally eligible (the “Senior Executive Benefits”). The Company may in its sole discretion change the Senior
Executive Benefits at any time; provided that, the Company shall maintain the benefits set forth on Annex A for a period of 12 months after the date hereof. 
 (b) During the Employment Period, the Company shall reimburse Executive for all reasonable business expenses incurred by him in the course of performing his duties and responsibilities under this Agreement, which
business expenses are consistent with the Company’s policies in effect from time to time with respect to travel, entertainment and other business expenses, subject to the Company’s requirements with respect to reporting and documentation
of such expenses. 
 (c) In addition to the Base Salary, Executive shall be eligible
to earn an annual bonus (“Annual Bonus”) in an amount equal to a certain percentage of the Base Salary then in effect, which percentage shall be determined by the Chief Executive Officer, after consultation with and approval by the
Board, and is based upon the achievement by Parent and its Subsidiaries of financial and other objectives established each year by the Board. An Annual Bonus, if any, will be earned as of February 1 and paid to Executive by the Company on or
before March 15th of the fiscal year following the fiscal year to which such Annual Bonus relates. 

 

 2 

 4. Term. 
 (a) The Employment Period shall end on the first anniversary of the date hereof, but shall automatically be renewed on the same terms and conditions set forth herein (as modified from time to time by the parties
hereto) for additional one-year periods beginning on the first anniversary of the date hereof and on each successive anniversary date, unless the Company or Executive gives the other party written notice of the election not to renew the Employment
Period at least 90 days prior to any such renewal date; provided that, the Employment Period shall terminate prior to such date immediately upon Executive’s resignation (with or without Good Reason, as defined below), death or Disability (as
defined below) or upon the Company’s termination of Executive’s employment (whether with Cause (as defined below) or without Cause). 
 (b) If the Employment Period is terminated (1) by the Company without Cause (other than as a result of Executive’s Disability) or (2) upon Executive’s resignation with Good Reason, Executive shall be entitled to
(i) his Base Salary through the date of termination, (ii) any bonus amounts to which Executive is entitled determined by reference to years that ended on or prior to the date of termination, (iii) an amount equal to one year of
Executive’s then current Base Salary plus an amount equal to the average of the Annual Bonus paid to Executive in respect of each of the two years immediately preceding the termination of Executive’s employment, and
(iv) running concurrently with his COBRA period, continued participation throughout the Severance Period (as defined below) in all health and dental benefit plans in which Executive was entitled to participate immediately prior to the
termination of Executive’s employment (or the Company shall arrange to make available to Executive benefits substantially similar to those which Executive would otherwise have been entitled to receive over such period if Executive’s
employment had not been terminated) on the same terms and conditions (including employee contributions toward premium payments) under which Executive was entitled to participate immediately prior to his termination, in each case if and only if
Executive has executed and delivered to the Company a general release substantially in the form of Exhibit A attached hereto and only if Executive does not breach the provisions of paragraphs 5, 6 and 7 hereof. The amounts payable pursuant to
clause (iii) of this paragraph 4(b) shall be payable in regular installments over 12 months (the “Severance Period”) in accordance with the Company’s general payroll practices. 
 (c) If the Employment Period is terminated (1) by the Company with Cause, (2) due to Executive’s death or Disability or (3) by
Executive’s resignation without Good Reason, Executive shall be entitled to receive (i) his Base Salary through the date of termination and (ii) any bonus amounts to which Executive is entitled determined by reference to years that
ended on or prior to the date of termination. 
 (d) Except as otherwise expressly provided herein. Executive shall not be entitled to any
other salary, bonuses, employee benefits or compensation from the Company or its Subsidiaries after the termination of the Employment Period and all of Executive’s rights to salary, bonuses, employee benefits and other compensation hereunder
which would have accrued or become payable after the termination of the Employment Period (other than vested retirement benefits accrued on or prior to the termination of the Employment Period or other amounts owing 

  

 3 

 
hereunder as of the date of such termination that have not yet been paid) shall cease upon such termination, other than those expressly required under
applicable law (such as COBRA). 
 (e) Executive is under no obligation to mitigate damages or the amount of any payment provided for
hereunder by seeking other employment or otherwise, and the Company shall have no right of offset for any amounts received by Executive from other employment; provided that, notwithstanding anything to the contrary herein, Executive’s coverage
under the Company’s health and dental benefit plans will terminate when Executive becomes eligible under any employee benefit plan made available by another employer covering health and dental benefits. The Executive shall notify the Company
within thirty (30) days after becoming eligible for any such benefits. 
 (f) The Company may offset any amounts Executive owes Parent
and its Subsidiaries against any amounts Parent and its Subsidiaries owe Executive hereunder. 
 (g) For purposes of this Agreement,
“Cause” shall mean, with respect to Executive, one or more of the following: (i) the indictment for a felony or other crime involving moral turpitude or the commission of any other act or any omission to act involving fraud
with respect to Parent or any of its Subsidiaries or any of their customers or suppliers; (ii) any act or any omission to act involving dishonesty or disloyally which causes, or in the good faith judgment of the Board would be reasonably likely
to cause, material harm (including reputational harm) to Parent or any of its Subsidiaries or any of their customers or suppliers; (iii) any (A) repeated abuse of alcohol or (B) abuse of controlled substances, in either case, that
adversely affects Executive’s work performance (and, in the case of clause (A), continues to occur at any time more than 30 days after Executive has been given written notice thereof) or brings Parent or its Subsidiaries into public disgrace or
disrepute; (iv) the failure by Executive to substantially perform duties as reasonably directed by the Board or Executive’s supervisor(s), which non-performance remains uncured for 10 days after written notice thereof is given to
Executive; (v) willful misconduct with respect to Parent or any of its Subsidiaries, which misconducts causes, or in the good faith judgment of the Board would be reasonably likely to cause, material harm (including reputational harm) to Parent
or any of its Subsidiaries; or (vi) any breach by Executive of paragraph 5, 6 or 7 of this Agreement or any other material breach of this Agreement or the Management Equity Plans (as defined below). 
 (h) Executive will be “Disabled” only if, as a result of his incapacity due to physical or mental illness, Executive is considered
disabled under the Company’s long-term disability insurance plans. 
 (i) For purposes of this Agreement, “Good Reason”
shall mean if Executive resigns from employment with the Company and its Subsidiaries prior to the end of the Employment Period as a result of one or more of the following reasons: (i) any reduction in Executive’s Base Salary or bonus
opportunity, without Executive’s prior consent, in either case other than any reduction which (A) is generally applicable to senior leadership team executives of the Company and (B) does not exceed 15% of Executive’s Base
Salary and bonus opportunity in the aggregate; (ii) any material breach by Parent or any of its Subsidiaries of any agreement between such Persons and Executive; (iii) a change in Executive’s principal office without 

  

 4 

 
Executive’s prior consent to a location that is more than 50 miles from Executive’s principal office on the date hereof; or (iv) delivery by
the Company of a notice of non-renewal of the Employment Period; provided that, any such reason was not cured by the Company to Participant’s reasonable satisfaction within 30 days after delivery of written notice thereof to the Company;
further provided that, in each case written notice of an Executive’s resignation with Good Reason must be delivered to the Company within 30 days after Executive has actual knowledge of the occurrence of any such event in order for
Executive’s resignation with Good Reason to be effective hereunder. 
 (j) For purposes of this Agreement, “Management Equity
Plans” shall mean the 2006 Management Option Plan of Parent, along with any Award Agreements (as defined therein) and any attachments thereto, as amended from time to time. 
 5. Confidential Information. 
 (a)
Executive acknowledges that the continued success of Parent and its Subsidiaries and Affiliates, depends upon the use and protection of a large body of confidential and proprietary information. All of such confidential and proprietary information
now existing or to be developed in the future will be referred to in this Agreement as “Confidential Information”. Confidential Information will be interpreted as broadly as possible to include all information of any sort (whether
merely remembered or embodied in a tangible or intangible form) that is (i) related to Parent’s or its Subsidiaries’ or Affiliates’ current or potential business and (ii) is not generally or publicly known. Confidential
Information includes, without specific limitation, the information, observations and data obtained by Executive during the course of his performance under this Agreement concerning the business and affairs of Parent and its Subsidiaries and
Affiliates, information concerning acquisition opportunities in or reasonably related to the Parent’s or its Subsidiaries’ or Affiliates’ business or industry of which Executive becomes aware during the Employment Period, the persons
or entities that are current, former or prospective suppliers or customers of any one or more of them during Executive’s course of performance under this Agreement, as well as development, transition and transformation plans, methodologies and
methods of doing business, strategic, marketing and expansion plans, including plans regarding planned and potential sales, financial and business plans, employee lists and telephone numbers, locations of sales representatives, new and existing
programs and services, prices and terms, customer service, integration processes, requirements and costs of providing service, support and equipment. Therefore, Executive agrees that during his employment and for a period of three (3) years
after termination of his employment for any reason (and as to information that constitutes a trade secret under applicable law, for such longer period as the same shall remain a trade secret) he shall not disclose to any unauthorized person or use
for his own account any of such Confidential Information without both Board’s prior written consent, unless and to the extent that any Confidential Information (i) becomes generally known to and available for use by the public other than
as a result of Executive’s acts or omissions to act or (ii) is required to be disclosed pursuant to any applicable law or court order. Executive agrees to deliver to the Company at the end of the Employment Period, or at any other time the
Company may request in writing, all memoranda, notes, plans, records, reports and other documents (and copies thereof) relating to the business of Parent or its Subsidiaries or Affiliates 

  

 5 

 
(including, without limitation, all Confidential Information) that he may then possess or have under his control. 
 (b) During the Employment Period, Executive shall not use or disclose any confidential information or trade secrets, if any, of any former employers or
any other person to whom Executive has an obligation of confidentiality, and shall not bring onto the premises of Parent or its Subsidiaries or Affiliates any unpublished documents or any properly belonging to any former employer or any other Person
to whom Executive has an obligation of confidentiality unless consented to in writing by the former employer or Person. Executive shall use in the performance of his duties only information that is (i) generally known and used by persons with
training and experience comparable to Executive’s and that is (x) common knowledge in the industry or (y) is otherwise legally in the public domain, (ii) otherwise provided or developed by Parent or its Subsidiaries or Affiliates
or (iii) in the case of materials, property or information belonging to any former employer or other Person to whom Executive has an obligation of confidentiality, approved for such use in writing by such former employer or Person. If at any
time during the Employment Period, Executive believes he is being asked to engage in work that will, or will be likely to, jeopardize any confidentiality or other obligations Executive may have to former employers, Executive shall immediately advise
the Board so that Executive’s duties can be modified appropriately. 
 (c) Executive represents and warrants to the Parent and its
Subsidiaries that Executive took nothing with him which belonged to any former employer when Executive left his position(s) with such employer(s) and that Executive has nothing that contains any information which belongs to any former employer. If
at any time Executive discovers that this representation is incorrect, Executive shall promptly return any such materials to Executive’s former employer(s). Parent and its Subsidiaries does not want any such materials, and Executive shall not
be permitted to use or refer to any such materials in the performance of Executive’s duties hereunder. 
 (d) Executive understands that Parent and its Subsidiaries and Affiliates will receive from third parties confidential or proprietary information (“Third Party Information”) subject to a duty on
Parent’s and its Subsidiaries’ and Affiliates’ part to maintain the confidentiality of such
information and to use it only for certain limited purposes. During the Employment Period and thereafter, and without in any way limiting the provisions of paragraph 5(a) above, Executive will hold Third Party Information in the strictest
confidence and will not disclose to anyone (other than personnel of Parent or its Subsidiaries and Affiliates who need to know such information in connection with their work for Parent or such Subsidiaries and Affiliates) or use, except in
connection with his work for Parent or its Subsidiaries and Affiliates, Third Party Information unless expressly authorized by a member of the Board in writing. 
 6. Intellectual Property. Inventions and Patents. Executive acknowledges that all discoveries, concepts, ideas, inventions, innovations, improvements, developments, methods, designs, analyses, drawings,
reports, patent applications, copyrightable work and mask work (whether or not including any confidential information) and all registrations or applications related thereto, all other proprietary information and all similar or related information
(whether or not patentable) which relate to Parent’s or any of its Subsidiaries’ actual or anticipated business, 

  

 6 

 
research and development or existing or future products or services and which are conceived, developed or made by Executive (whether alone or jointly with
others) while employed by the Company and its Subsidiaries, whether before or after the date of this Agreement (“Work Product”), belong to Parent, the Company or such Subsidiary. Executive shall promptly disclose such Work Product
to the Board and, at the Company’s expense, perform all actions reasonably requested by the Board (whether during or after the Employment Period) to establish and confirm such ownership (including, without limitation, assignments, consents,
powers of attorney and other instruments). 
 7. Non-Compete: Non-Solicitation. 
 (a) In further consideration of the compensation to be paid to Executive hereunder, Executive
acknowledges that during the course of his employment with the Company and its Subsidiaries he has and shall become familiar with Parent’s and its Subsidiaries’ and Affiliates’ corporate strategy, pricing and other
market information, know-how, trade secrets and valuable customer, supplier and employee relationships, and with other Confidential Information concerning Parent and its Subsidiaries and Affiliates, and that his services have been and shall be of
special, unique and extraordinary value to Parent and its Subsidiaries and Affiliates. Accordingly, Executive agrees that, during the Employment Period and for one (1) year thereafter (the “Noncompete Period”), he shall not
directly or indirectly own any interest in, manage, control, participate in, consult with, render services for, or in any manner engage in any Competing Business that conducts operations or sales in Japan, Holland, Germany, Korea, China, Malaysia,
Mexico, or Brazil, or in the United States within any of the following states: Michigan, Wisconsin, Illinois, New York, Ohio, Indiana, Connecticut, Iowa, Pennsylvania, Missouri, Massachusetts, California, North Carolina, Texas, Indiana, Illinois,
Kentucky, Mississippi, Washington, Tennessee, Virginia, New Jersey, Idaho, Colorado, Alabama, Georgia, South Carolina, Florida, or Maryland (and, in the event the Company and/or any of its Subsidiaries or Affiliates conducts operations or sales in
other jurisdictions after the date hereof, such other jurisdictions, provided that the Company updates this list of jurisdictions by delivering written notice to Executive). Nothing herein shall prohibit Executive from being a passive owner of not
more than 2% of the outstanding stock of any class of a corporation which is publicly traded, so long as Executive has no active participation in the business of such corporation. For purpose of this Agreement, “Competing
Business” shall mean any business engaged (whether directly or indirectly) in the design, manufacture, marketing, or sale of electromechanical or electronic sensors or controls. 
 (b) During the Noncompete Period, Executive shall not directly or indirectly through another person or entity (i) induce or attempt to induce any
employee of Parent or any Subsidiary to leave the employ of Parent or such Subsidiary, or in any way interfere with the relationship between Parent or any Subsidiary and any employee thereof, (ii) knowingly hire any person who was an employee
of Parent or any Subsidiary at any time during the twelve months prior to the termination of Executive’s employment or (iii) induce or encourage any customer, supplier, licensee, licensor or other business relation of Parent or any
Subsidiary to cease doing business with Parent or such Subsidiary, or in any way interfere with the relationship between any such customer, supplier, licensee, licensor or business relation and Parent or any Subsidiary (including, without
limitation, making any negative or disparaging statements or communications 

  

 7 

 
regarding Parent or its Subsidiaries); provided that, in each case, this paragraph 7(b) shall only apply if Executive shall have done business with, or had
supervisory or other responsibility for, the employee, customer, supplier, licensee, licensor, or business relation to which the applicable clause of this paragraph 7(b) applies. 
 (c) If, at the time of enforcement of this paragraph 7, a court shall hold that the duration, scope or area restrictions stated herein are unreasonable
under circumstances then existing, the parties agree that the maximum duration, scope or area reasonable under such circumstances shall be substituted for the stated duration, scope or area and that the court shall be allowed to revise the
restrictions contained herein to cover the maximum period, scope and area permitted by law. Executive acknowledges that the restrictions contained in this paragraph 7 are reasonable and that he has reviewed the provisions of this Agreement with his
legal counsel. 
 (d) Executive acknowledges that any breach or threatened breach of the provisions of this paragraph 7 would cause Parent
and its Subsidiaries irreparable harm. Accordingly, in addition to other rights and remedies existing in its favor, the Company shall be entitled to specific performance and/or injunctive or other equitable relief from a court of competent
jurisdiction in order to enforce or prevent any violations of the provisions hereof (without posting a bond or other security). Further, in the event of an alleged breach or violation by Executive of this paragraph 7, the Noncompete Period shall be
tolled until such breach or violation has been duly cured. 
 8. Executive’s Representations. Executive hereby represents and
warrants to the Company that (a) the execution, delivery and performance of this Agreement by Executive do not and shall not conflict with, breach, violate or cause a default under any contract, agreement, instrument, order, judgment or decree
to which Executive is a party or by which he is bound, (b) Executive is not a party to or bound by any employment agreement, noncompete agreement or confidentiality agreement with any other person or entity and (c) upon the execution and
delivery of this Agreement by the Company, this Agreement shall be the valid and binding obligation of Executive, enforceable in accordance with its terms. Executive hereby acknowledges and represents that he has consulted with independent legal
counsel regarding his rights and obligations under this Agreement and that he fully understands the terms and conditions contained herein. 
 9. Survival. Paragraphs 4 through 23 (other than paragraph 21) shall survive and continue in full force in accordance with their terms notwithstanding the termination of the Employment Period. 
 10. Notices. Any notice provided for in this Agreement shall be in writing and shall be either personally delivered, sent by reputable overnight
courier service or mailed by first class mail, return receipt requested, to the recipient at the address below indicated: 
  

 8 

					
	Notices to Executive:	 		 	
	
	 Jeffrey Cote
 111 Milton Street
 Milton, MA 02186

			
	Notices to the Company:	 		 	
	
	 Sensata Technologies, Inc.
 529 Pleasant Street
 Attleboro, MA 02703

	 Attention:
	 	Senior Counsel
			
	With a copy to:	 		 	
	
	 Bain Capital Partners, LLC
 745 Fifth Avenue
 New York, New York 10151

	 Attention:
	 	Ed Conard
		 	 Paul Edgerley
 Stephen M.
Zide

			
	 and
	 		 	
	
	 Kirkland & Ellis LLP
 200 East Randolph Drive
 Chicago, Illinois 60601

	 Attention:
	 	Matthew E. Steinmetz, P.C.
		 	Jeffrey W. Richards

 or such other address or to the attention of such other person as the recipient party shall have specified by
prior written notice to the sending party. Any notice under this Agreement shall be deemed to have been given when so delivered, sent or mailed. 
 11. Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or
unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision of this Agreement or any action in any other jurisdiction, but this Agreement
shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein. 
 12. Complete Agreement. This Agreement, those documents expressly referred to herein and other documents of even date herewith embody the complete agreement and understanding among the parties and supersede and
preempt any prior understandings, agreements or representations by or among the parties, written or oral, which may have related to the subject matter hereof in any way. 
  

 9 

 13. No Strict Construction. The language used in this Agreement shall be deemed to be the language
chosen by the parties hereto to express their mutual intent, and no rule of strict construction shall be applied against any party. 
 14.
Counterparts. This Agreement may be executed in separate counterparts (including by means of facsimile), each of which is deemed to be an original and all of which taken together constitute one and the same agreement. 
 15. Successors and Assigns. This Agreement will be binding upon and inure to the benefit of the Company and any successor to the Company,
including, without limitation, any Persons acquiring directly or indirectly all or substantially all of the business or assets of the Company whether by purchase, merger, consolidation, reorganization or otherwise (and such successor shall
thereafter be deemed the “Company” for the purposes of this Agreement), but will not otherwise be assignable, transferable or delegable by the Company other than to Parent or any of its Subsidiaries. This Agreement will inure to the
benefit of and be enforceable by Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees and legatees, but otherwise will not otherwise be assignable, transferable or delegable by Executive.
This Agreement is personal in nature and neither of the parties hereto shall, without the consent of the other, assign, transfer or delegate this Agreement or any rights or obligations hereunder except as otherwise expressly provided in this
paragraph 15. 
 16. Choice of Law. All issues and questions concerning the construction, validity, enforcement and interpretation of
this Agreement and the exhibits and schedules hereto shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State
of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. 
 17. Amendment and Waiver. The provisions of this Agreement may be amended or waived only with the prior written consent of the Company (as approved by the Board) and Executive, and no course of conduct or course of dealing or failure
or delay by any party hereto in enforcing or exercising any of the provisions of this Agreement (including, without limitation, the Company’s right to terminate the Employment Period with Cause or, except as otherwise stated herein.
Executive’s right to terminate the Employment Agreement with Good Reason) shall affect the validity, binding effect or enforceability of this Agreement or be deemed to be an implied waiver of any provision of this Agreement. 
 18. Insurance. The Company may, at its discretion, apply for and procure in its own name and for its own benefit life and/or disability insurance
on Executive in any amount or amounts considered advisable. Executive agrees to cooperate in any medical or other examination, supply any information and execute and deliver any applications or other instruments in writing as may be reasonably
necessary to obtain and constitute such insurance. 
 19. Indemnification and Reimbursement of Payments on Behalf of Executive. The
Company and its respective Subsidiaries shall be entitled to deduct or withhold from any amounts owing from the Company or any of its Subsidiaries to Executive any federal, state, local 

  

 10 

 
or foreign withholding taxes, excise tax, or employment taxes (“Taxes”) imposed with respect to Executive’s compensation or other
payments from the Company or any of its Subsidiaries or Executive’s ownership interest in Parent (including, without limitation, wages, bonuses, dividends, the receipt or exercise of equity options and/or the receipt or vesting of restricted
equity). In the event the Company or any of its Subsidiaries does not make such deductions or withholdings, Executive shall indemnify the Company and its Subsidiaries for any amounts paid with respect to any such Taxes, together (if such failure to
withhold was at the written direction of Executive) with any interest, penalties and related expenses thereto. 
 20. Waiver of Jury
Trial. AS A SPECIFICALLY BARGAINED FOR INDUCEMENT FOR EACH OF THE PARTIES HERETO TO ENTER INTO THIS AGREEMENT (AFTER HAVING THE OPPORTUNITY TO CONSULT WITH COUNSEL). EACH PARTY HERETO EXPRESSLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY LAWSUIT OR
PROCEEDING RELATING TO OR ARISING IN ANY WAY FROM THIS AGREEMENT OR THE MATTERS CONTEMPLATED HEREBY. 
 21. Corporate Opportunity.
During the Employment Period, Executive shall submit to the Board all business, commercial and investment opportunities or offers presented to Executive, or of which Executive becomes aware, at any time during the Employment Period, which
opportunities relate to the business of designing, manufacturing, marketing, or selling electromechanical or electronic sensors or controls (“Corporate Opportunities”). During the Employment Period, unless approved by the Board,
Executive shall not accept or pursue, directly or indirectly, any Corporate Opportunities on Executive’s own behalf. 
 22.
Executive’s Cooperation. During the Employment Period and thereafter, Executive shall reasonably cooperate with Parent and its Subsidiaries in any internal investigation or administrative, regulatory or judicial proceeding as reasonably
requested by Parent or any Subsidiary (including, without limitation, Executive being available to Parent and its Subsidiaries upon reasonable notice for interviews and factual investigations, appearing at Parent’s or any Subsidiary’s
request to give truthful and accurate testimony without requiring service of a subpoena or other legal process, volunteering to Parent and its Subsidiaries all pertinent information and turning over to Parent and its Subsidiaries all relevant
documents which are or may come into Executive’s possession, all at times and on schedules that are reasonably consistent with Executive’s other permitted activities and commitments). In the event Parent or any Subsidiary requires
Executive’s cooperation in accordance with this paragraph, Parent shall pay Executive a per diem reasonably determined by the Board and reimburse Executive for reasonable expenses incurred in connection therewith (including lodging and meals,
upon submission of receipts). 
 23. Nondisparagement. Executive agrees not to, except as may be required by law, directly or
indirectly, publicly or privately, make, publish or solicit, or encourage others to make, publish or solicit, any disparaging statements, comments, announcements, or remarks concerning Parent or its Affiliates, or any of their respective past and
present directors, officers or employees. Parent and its Affiliates agree not to, except as may be required by law, directly or indirectly, publicly or privately, make, publish or solicit, or encourage others to make, publish or solicit, any
disparaging statements, comments, announcements or remarks concerning Executive or his employment with the Company or any of its Subsidiaries. 
 *    *    *    *    * 
  

 11 

 IN WITNESS WHEREOF, the parties hereto have executed this Employment Agreement as of the date first
written above. 
  

			
	 SENSATA TECHNOLOGIES, INC.

		
	 By:
	 	 /s/ Thomas Wroe, Jr.

	 Name:
	 	Thomas Wroe, Jr.
	 Title:
	 	Chief Executive Officer
	
	 /s/ Jeffrey Cote

	 Jeffrey Cote

  

 12 

 ANNEX A 
  

	 	i.	annual physical medical analysis 

  

	 	ii.	financial counseling services 

 EXHIBIT A 
 Form of Release Agreement 

 SENSATA TECHNOLOGIES, INC. 
                     ,         

 Dear employee: 
 This letter will confirm
the Agreement between you and Sensata Technologies, Inc. as follows: 
  

	 	1.	Separation from the Company 

 By signing this
agreement you acknowledge that your separation from Sensata Technologies, Inc. will be effective on                     ,
         (the “Separation Date”). As of the Separation Date, you will no longer be required to fulfill any of the duties and responsibilities associated with your position. 
  

	 	2.	Severance Payment 

 In exchange for your execution
of this Agreement, including the Release in paragraph 3, the Company agrees to pay you: [SPECIFY,], in twelve monthly installments of             , less deductions required by
law (“Severance Payments”). Such Severance Payments will not be made until this agreement becomes effective and enforceable. Such Severance Payments shall not be considered compensation for purposes of any employee benefit plan,
program, policy or arrangement maintained or hereafter established by the Company or any of its affiliates. You understand that the Severance Payments made to you represent consideration for signing this Release and are not salary, wages or benefits
to which you were already entitled. You also acknowledge and represent that you have already received everything to which you were entitled by virtue of your employment relationship with the Company. 
  

	 	3.	Release by You 

  

	 	(a)	 You (for yourself, your heirs, assigns or executors) release and forever discharge the Company, any of its affiliates, and its and their directors, officers, agents
and employees from any and all claims, suits, demands, causes of action, contracts, covenants, obligations, debts, costs, expenses, attorneys’ fees, liabilities of whatever kind or nature in law or equity, by statute or otherwise whether now
known or unknown, vested or contingent, suspected or unsuspected, and whether or not concealed or hidden, which have existed or may have existed, or which do exist, through the date this letter agreement becomes effective and enforceable,
(“Claims”) of any kind, which relate in any way to your employment with the Company or the termination of that employment, except those arising out of the performance of this letter agreement, your rights under the employee benefit
plans of the Company and your rights to accrued, unused vacation and sick leave. Such 

	 	 
released claims include, without in any way limiting the generality of the foregoing language, any and all claims of employment discrimination under any
local, state, or federal law or ordinance, including, without limitation, Title VII or the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; the Americans with Disabilities Act of 1990; the Age Discrimination in Employment Act of
1967, as amended, 

  

	 	(b)	In signing this Release you acknowledge that you intend that it shall be effective as a bar to each and every one of the Claims hereinabove mentioned or implied. You expressly
consent that this Release shall be given full force and effect according to each and all of its express terms and provisions, including those relating to unknown and unsuspected Claims (notwithstanding any state statute that expressly limits the
effectiveness of a general release of unknown, unsuspected and unanticipated Claims), if any, as well as those relating to any other Claims hereinabove mentioned or implied. You acknowledge and agree that this waiver is an essential and material
term of this Release and without such waiver the Company would not have made the Severance Payments described in paragraph 2. You further agree that in the event you bring your own Claim in which you seek damages against the Company, or in the event
you seek to recover against the Company in any Claim brought by a governmental agency on your behalf, this release shall serve as a complete defense to such Claims. 

  

	 	(c)	By signing this letter agreement, you acknowledge that you: 

  

	 	(1)	have been given twenty-one days after receipt of this letter agreement within which to consider it; 

  

	 	(2)	have carefully read and fully understand all of the provisions of this letter agreement; 

  

	 	(3)	knowingly and voluntarily agree to all of the terms set forth in this letter agreement; 

  

	 	(4)	knowingly and voluntarily agree to be legally bound by this letter agreement; 

  

	 	(5)	have been advised and encouraged in writing (via this agreement) to consult with an attorney prior to signing this letter agreement; 

  

	 	(6)	understand that this letter agreement, including the Release, shall not become effective and enforceable until the eighth day following execution of this letter agreement, and that
at any time prior to the effective day you can revoke this letter agreement. 

  

	 	4.	Additional Agreements 

 (a) You also
agree not to, except as may be required by law, directly or indirectly, publicly or privately, make, publish or solicit, or encourage others to make, 

  

 2 

 
publish or solicit, any disparaging statements, comments, announcements, or remarks concerning Company, any of its affiliates, or any of their respective
past and present directors, officers or employees. The Company agrees not to, except as may be required by law, directly or indirectly, publicly or privately, make, publish or solicit, or encourage others to make, publish or solicit, any disparaging
statements, comments, announcements or remarks concerning you or your employment with the Company. 
 (b) You further agree to
keep all confidential and proprietary information about the past or present business affairs of the Company confidential unless a prior written release from the Company is obtained. 
 (c) You further agree that as of the date hereof, you have returned to the Company any and all property, tangible or intangible, relating
to its business, which you possessed or had control over at any time, including, but not limited to, company-provided credit cards, building or office access cards, keys, computer equipment, manuals, files, documents, records, software, customer
data base and other data, and that you shall not retain any copies, compilations, extracts, excerpts, summaries or other notes of any such manuals, files, documents, records, software, customer data base or other data. 
  

	 	5.	Confidentiality of this Letter Agreement 

 The
contents of this letter agreement, including, but not limited to, its financial terms, are strictly confidential. By signing this agreement you agree and represent that you will maintain the confidential nature of the agreement, except (a) in
disclosing it to legal counsel, tax and financial planners, and immediate family who agree to keep it confidential; (b) as otherwise required by law, in which case you shall notify the Company in writing in advance of disclosure; and
(c) as necessary to enforce this letter agreement. 
 The Company agrees that it will keep the contents of this letter agreement
confidential, except (a) to its executive staff and governing bodies, as necessary or appropriate, and to its outside counsel and auditors; (b) as otherwise required by law; and (c) as necessary to enforce this letter agreement.

  

	 	6.	No Transferor Assignment 

 You and the Company agree
that no interest or right you have or any of your beneficiaries has to receive payment or to receive benefits under this Agreement shall be subject in any manner to sale, transfer, assignment, pledge, attachment, garnishment, or other alienation or
encumbrance of any kind, except as required by Jaw. Nor may such interest or right to receive payment or distribution be taken, voluntarily or involuntarily, for the satisfaction of the obligations or debts of, or other claims against you or your
beneficiary, including for alimony, except to the extent required by law. 
  

	 	7.	No Admissions 

 This letter agreement shall not be
construed as an admission of any wrongdoing either by the Company, its affiliates, or its and their directors, officers, agents and employees. 
  

 3 

	 	8.	No Other Agreement 

 This letter agreement contains
the entire agreement between you and the Company. No part of this letter agreement may be changed except in writing, executed by both you and the Company. 
  

	 	9.	Governing Law 

 This letter agreement shall be
interpreted in accordance with the laws of the State of New York. Whenever possible, each provision of this letter agreement shall be interpreted in a manner as to be effective and valid under applicable law, but if any provision shall be held to be
prohibited or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without invalidating or affecting the remainder of such provision or any of the remaining provisions of this letter
agreement. 
  

	 	10.	Counterparts 

 This Agreement may be executed in
separate counterparts, each of which is deemed to be an original and all of which taken together constitute one and the same Agreement. 
  

 4 

 Please indicate your agreement by signing this letter and returning it to us on or before
                     ,         . 
  

			
	Very truly yours,
	
	Sensata Technologies, Inc.
		
	By:	 	  

	Name:	 	
	Its:	 	

 AGREED TO AND ACCEPTED BY: 
  

			
	  

	[Name]
		
	Dated:	 	  

  

 5Form of Unit Purchase Option

 Exhibit 4.42 
 UNIT PURCHASE OPTION 
 FOR THE PURCHASE OF 
 4.0162 UNITS 
 OF 
 SYNOVA HEALTHCARE GROUP, INC. 
 1. Purchase Option.

 THIS CERTIFIES THAT G.M. Capital Partners, Ltd. (“Holder”), as registered owner of this Unit Purchase Option (this
“Purchase Option”), is entitled, at any time or from time to time until 5:00 p.m., Eastern Time, March 31, 2010 (“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part 4.0162
units of the Company, each such unit consisting of 33,333 shares of Common Stock and a warrant to purchase 16,666 shares of Common Stock at an exercise price of $2.50 per share, which warrants expire March 31, 2010. When used herein, the terms
“Units” and “Warrants” shall refer to the units and warrants described in this paragraph. 
 This Purchase Option is
initially exercisable at $50,000 per Unit so purchased; provided, however, that upon the occurrence of any of the events specified in Section 4 hereof, the rights granted by this Purchase Option, including the exercise price per Unit and the
number of Units (and shares of underlying Common Stock and Warrants) to be received upon such exercise, shall be adjusted as described herein. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price,
depending on the context. 
 2. Exercise. 
 2.1 Exercise Form. In order to exercise this Purchase Option, the exercise form attached hereto must be duly executed and completed and delivered to the Company, together with this Purchase Option and payment of the Exercise
Price for the Units being purchased payable in cash or by certified check or official bank check. If the subscription rights represented hereby shall not be exercised at or before 5:00 p.m., Eastern time, on the Expiration Date this Purchase Option
shall become and be void without further force or effect, and all rights represented hereby shall cease and expire. 
 2.2 Legend.
This Purchase Option and each certificate for the securities purchased under this Purchase Option shall bear a legend as follows: 
 “The securities represented by this certificate have not been registered under the Securities Act of 1933, as amended (the “Act”) or applicable state laws. The securities may not be offered for sale, sold or otherwise
transferred except pursuant to an effective registration statement under the Act and applicable state laws, or pursuant to an exemption from registration under the Act and applicable state laws.” 

 2. Transfer. 
 2.1 General Restrictions. In order to make any permitted assignment of this Unit Purchase Option, the Holder must deliver to the Company the assignment form attached hereto duly executed and completed, together with the
Purchase Option and payment of all transfer taxes, if any, payable in connection therewith. The Company shall within five business days transfer this Purchase Option on the books of the Company and shall execute and deliver a new Purchase Option or
Purchase Options of like tenor to the appropriate assignee(s) expressly evidencing the right to purchase the aggregate number of Units purchasable hereunder or such portion of such number as shall be contemplated by any such assignment.
Notwithstanding the foregoing, the Company may condition any assignment or transfer of this Purchase Option upon the delivery of a legal opinion to the effect that such assignment or transfer is in compliance with all applicable laws, such opinion
to be in form and substance reasonably satisfactory to the Company. 
 2.2 Restrictions Imposed by the Act. The securities
evidenced by this Purchase Option shall not be transferred or assigned unless and until (i) the Company has received the opinion of counsel for the Holder that the securities may be transferred pursuant to an exemption from registration under
the Act and applicable state securities laws, the availability of which is established to the reasonable satisfaction of the Company, or (ii) a registration statement or a post-effective amendment to the Registration Statement relating to such
securities has been filed by the Company and declared effective by the Securities and Exchange Commission and compliance with applicable state securities law has been established to the reasonable satisfaction of the Company. 
 3. New Purchase Options to be Issued. 
 3.1
Partial Exercise or Transfer. This Purchase Option may be exercised or assigned (subject to Section 2) in whole or in part any time prior to the Expiration Date. In the event of the exercise or assignment hereof in part only, upon
surrender of this Purchase Option for cancellation, together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer tax, the Company shall cause to be delivered to the Holder without charge
a new Purchase Option of like tenor to this Purchase Option in the name of the Holder evidencing the right of the Holder to purchase the number of Units purchasable hereunder as to which this Purchase Option has not been exercised or assigned.

 3.2 Lost Certificate. Upon receipt by the Company of evidence satisfactory to it (in its sole discretion) of the loss,
theft, destruction or mutilation of this Purchase Option and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a new Purchase Option of like tenor and date. Any such new Purchase Option
executed and delivered as a result of such loss, theft, mutilation or destruction shall constitute a substitute contractual obligation on the part of the Company. 
  

 2 

 4. Adjustments. The Exercise Price and the number of Units underlying the Purchase Option shall be subject to
adjustment from time to time as hereinafter set forth: 
 4.1 Stock Dividends - Split-Ups. If after the date hereof, and subject
to the provisions of Section 4.3 below, the number of outstanding shares of Common Stock is increased by a stock dividend payable in shares of Common Stock or by a split-up of shares of Common Stock or other similar event, then, on the
effective date thereof, the number of shares of Common Stock underlying each of the Units purchasable hereunder shall be increased in proportion to such increase in outstanding shares. In such case, the number of shares of Common Stock, and the
exercise price applicable thereto, underlying the Warrants underlying each of the Units purchasable hereunder shall be adjusted in accordance with the terms of the Warrants. 
 4.2 Aggregation of Shares. If after the date hereof, and subject to the provisions of Section 4.1, the number of outstanding shares of
Common Stock is decreased by a consolidation, combination or reclassification of shares of Common Stock or other similar event, then, on the effective date thereof, the number of shares of Common Stock underlying each of the Units purchasable
hereunder shall be decreased in proportion to such decrease in outstanding shares. In such case, the number of shares of Common Stock, and the exercise price applicable thereto, underlying the Warrants underlying each of the Units purchasable
hereunder shall be adjusted in accordance with the terms of the Warrants. 
 4.3 Replacement of Securities upon Reorganization, etc.
In case of any reclassification or reorganization of the outstanding shares of Common Stock other than a change covered by Section 4.1 or 4.2 hereof or that solely affects the par value of such shares of Common Stock, or in the case of
any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the
outstanding shares of Common Stock), or in the case of any sale or conveyance to another corporation or entity of the assets of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the Holder
of this Purchase Option shall have the right thereafter (until the Expiration Date) to receive upon the exercise hereof, for the same aggregate Exercise Price (plus the aggregate exercise price under the Warrants underlying this Purchase Option)
payable hereunder immediately prior to such event, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution
following any such sale or transfer, by a Holder of the number of shares of Common Stock of the Company obtainable upon exercise of this Purchase Option and the underlying Warrants immediately prior to such event. The provisions of this
Section 4.4 shall apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. 
 4.4 Changes in Form of Purchase Option. This form of Purchase Option need not be changed because of any change pursuant to this Section, and Purchase Options issued after such change may state the same Exercise Price and the
same number of Units as are stated in this Purchase Option. The acceptance by any Holder of the issuance of new Purchase Options reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring after the
date of such change. 
  

 3 

 4.5 Substitute Purchase Option. In case of an adjustment pursuant to this Section 4,
the Company shall promptly deliver to the Holder a certificate of adjustment setting forth the adjustments to this Purchase Option and the calculation thereof. 
 4.6 Elimination of Fractional Interests. The Company shall not be required to issue certificates representing fractions of shares of Common Stock or Warrants upon the exercise of the Purchase Option, nor
shall it be required to issue scrip or pay cash in lieu of any fractional interests, it being the intent of the parties that all fractional interests shall be eliminated by rounding any fraction to the nearest whole number of shares of Common Stock
or other securities, properties or rights. 
 5. Reservation and Listing. The Company shall at all times reserve and keep available out of its
authorized shares of Common Stock, solely for the purpose of issuance upon exercise of this Purchase Option or the Warrants underlying this Purchase Option, such number of shares of Common Stock or other securities, properties or rights as shall be
issuable upon the exercise thereof. The Company covenants and agrees that, upon exercise of this Purchase Option and payment of the aggregate Exercise Price therefor, all shares of Common Stock and other securities issuable upon such exercise shall
be duly and validly issued, fully paid and non-assessable. The Company further covenants and agrees that upon exercise of the Warrants underlying this Purchase Option and payment of the aggregate Warrant exercise price therefor, all shares of Common
Stock and other securities issuable upon such exercise shall be duly and validly issued, fully paid and non-assessable. 
 6. Certain Notice Requirements.

 6.1 Holder’s Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holders the right to
vote or consent as a stockholder for the election of directors or any other matter, or as having any rights whatsoever as a stockholder of the Company. If, however, at any time prior to the Expiration Date or the exercise of this Purchase Option,
any of the events described in Section 6.2 shall occur, then, in one or more of said events, the Company shall give written notice of such event at least five days prior to the date fixed as a record date or the date of closing the transfer
books for the determination of the stockholders entitled to such dividend, distribution, conversion or exchange of securities or subscription rights, or entitled to vote on such proposed dissolution, liquidation, winding up or sale. Such notice
shall specify such record date or the date of the closing of the transfer books, as the case may be. 
 6.2 Events Requiring
Notice. The Company shall be required to give the notice described in this Section 6 upon one or more of the following events: (i) if the Company shall take a record of the holders of its shares of Common Stock for the purpose of
entitling them to receive a dividend or distribution payable otherwise than in cash or (ii) the Company shall offer to all the holders of its Common Stock any additional shares of capital stock of the Company or securities convertible into or
exchangeable for shares of capital stock of the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation or winding up of the Company (other than in connection with a consolidation or merger) or a sale
of all or substantially all of its property, assets and business shall be proposed. 
  

 4 

 6.3 Transmittal of Notices. All notices, requests, consents and other communications under
this Purchase Option shall be in writing and shall be deemed to have been duly made when hand delivered, or mailed by express mail or private courier service: (i) if to the registered Holder of this Purchase Option, to the address of such
Holder as shown on the books of the Company, or (ii) if to the Company, to the following address or to such other address as the Company may designate by notice to the Holders: 
 Synova Healthcare Group, Inc. 
 Attn:
Stephen E. King, Chief Executive Officer 
 1400 North Providence Road 
 Media, PA 19063 
 Tel. 610 565-7080 ext 101

 Fax 610 565-7081 
 7. Miscellaneous.

 7.1 Amendments. All modifications or amendments shall require the written consent of and be signed by the party against
whom enforcement of the modification or amendment is sought. 
 7.2 Headings. The headings contained herein are for the sole
purpose of convenience of reference, and shall not in any way limit or affect the meaning or interpretation of any of the terms or provisions of this Purchase Option. 
 7.3. Entire Agreement. This Purchase Option (together with the other agreements and documents being delivered pursuant to or in connection with this Purchase Option) constitutes the entire agreement of
the parties hereto with respect to the subject matter hereof, and supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof. 
 7.4 Binding Effect. This Purchase Option shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and
their permitted assignees and, respective successors, and no other person shall have or be construed to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Purchase Option or any provisions herein
contained. 
 7.5 Governing Law; Submission to Jurisdiction. This Purchase Option shall be governed by and construed and
enforced in accordance with the laws of the State of Delaware, without giving effect to conflict of laws. The Company and the Holder hereby agree that any action, proceeding or claim against arising out of, or relating in any way to, this Purchase
Option shall be brought and enforced in the state or federal courts located in the State of Delaware, and the Company and the Holder hereby irrevocably submit to such jurisdictions, which jurisdictions shall be exclusive. The Company and the Holder
hereby waive any objection to such exclusive jurisdictions and that such courts represent an inconvenient forum. Any process or summons to be served upon the Company or the Holder may be served by transmitting a copy thereof by 

  

 5 

 
registered or certified mail, return receipt requested, postage prepaid, addressed to the Company or the Holder, as applicable, at the address set forth in
Section 6 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company and the Holder in any action, proceeding or claim. The Company and the Holder agree that the prevailing party(ies) in any such
action shall be entitled to recover from the other party(ies) all of its reasonable attorneys’ fees and expenses relating to such action or proceeding and/or incurred in connection with the preparation therefor. The Holder (including any
permitted transferees hereunder), by acceptance hereof, accepts, and agrees to be bound by, all of the obligations of the Holder under this Section and the other provisions of this Purchase Option. 
 7.6 Waiver, Etc. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Option shall not be
deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Option or any provision hereof or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase
Option. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this Purchase Option shall be effective unless set forth in a written instrument executed by the party or parties against whom or which enforcement of
such waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment. 
  

 6 

 IN WITNESS WHEREOF, the Company has caused this Purchase Option to be signed by its duly authorized
officer as of the 31st day of March, 2006. 
  

			
	SYNOVA HEALTHCARE GROUP, INC.
		
	By:	 	 /s/ Stephen E. King

	Name:	 	Stephen E. King
	Title:	 	Chairman and Chief Executive Officer

  

 7 

 Form to be used to exercise Purchase Option: 
 Synova Healthcare Group, Inc. 
 Attn: Stephen E. King, Chief Executive Officer 
 1400 North Providence Road 
 Media, PA 19063 
 Tel. 610 565-7080 ext 101 
 Fax 610 565-7081 
 Date:                    , 200    

 The undersigned hereby elects irrevocably to exercise all or a portion of the within Purchase Option and to purchase the following:

              Units of Synova Healthcare Group, Inc., exercisable for
25,000 shares of Common Stock and Warrants to purchase 12,500 shares of Common Stock at an exercise price of $3.00 per share. 
 +                     Units of Synova Healthcare Group, Inc. exercisable for 33,333 shares of Common Stock and Warrants to purchase
16,666 shares of Common Stock at an exercise price of $2.50 per share. 
 =                     Total Units to be exercised 
 and hereby makes aggregate payment of $             (equal to the Total Units to be exercise multiplied by $50,000 for each such Unit) in payment of
the Exercise Price pursuant thereto. Please issue the Common Stock and Warrants as to which this Purchase Option is exercised in accordance with the instructions given below. 
  

	
	  

	Signature
	
	  

	Signature Guaranteed

  

 8 

 Form to be used to assign Purchase Option: 
 ASSIGNMENT 
 (To be executed by the registered Holder to effect a transfer of
the within Purchase Option): 
 FOR VALUE
RECEIVED,                                      
                                   does hereby sell, assign and transfer
unto                                       
                                        
      the right to purchase                      Units of Synova Healthcare Group, Inc. (“Company”)
evidenced by the within Purchase Option and does hereby authorize the Company to transfer such right on the books of the Company. 
 Dated:                        , 200     
  

	
	  

	Signature

  

 9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}]]